The use of small volume ocular sprays to improve the bioavailability of topically applied ophthalmic drugs

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 44, Issue 2, 1997, Pages 121-126

  Martini, Luigi G ^a   Embleton, Jonathan K ^a   Malcolmson, Richard J ^a   Wilson, Clive G ^b  

^a Scherer Drug Delivery Systems   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bioavailability; Drop volume; Nasolacrimal drainage miotic response; Ocular sprays

Indexed keywords

EYE DROPS; FLUORESCEIN; PILOCARPINE; SODIUM CHLORIDE;

AEROSOL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; LACRIMAL DUCT; MALE; MIOSIS; NONHUMAN; PHARMACODYNAMICS; RABBIT; SUBCONJUNCTIVAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0031390411     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00071-4     Document Type: Article

References (23)

1. C.M. Lederer, R.-E. Harold, Dropsize of commercial glaucoma medications, Am. J. Ophthahnot. 101 (1986) 691-694.
2. S. Misliima, A. Gasset, S.O. Klyce, J.L. Baum, Determination of tear volume and tear flow, Invest. Ophthalmol. Sci. 5 (1966) 264-276.
3. J.W. Shell, Pharmacokinetics of topically applied ophthalmic drugs, Surv. Ophthalmol. 26 (1982) 207-219.
4. E.M. Van Buskivk, Adverse reactions froin timolol administration, Ophthalmology 87 (1986) 447-450.
5. W.L. Nelson, F.T. Fraunfelder, J.M. Sills, J.B. Arrowsmith, J.N. Krvitsky, Adverse respiratory and cardiovascular events attributed to timolol ophthamic solutions, Am. J. Ophthahmol. 102 (1986) 606-611.
6. S.S. Chrai, T.F. Patton, A. Mehta, J.R. Robinson, Lacrimal and instilled fluid dynamics in rabbit eyes, J. Pharm. Sci. 62 (1973) 1112-1121.
7. S.S. Chrai, M.C. Makoid, S.P. Eriksen, J.R. Robinson, Drop size and dosing frequency problems of topically applied ophthalmic drugs, J. Pharm. Sci. 63 (1974) 333-358.
8. T.F. Patton, Pharmacokinetic evidence for improved drug delivery by reduction of instilled volume. J. Pharm. Sci. 66 (1977) 1058-1059.
9. Scherer Drug Delivery Systems, Unpublished data.
10. J.L. Greaves, C.G. Wilson, A.T. Birmingham, M.C. Richardson. P.M. Bentley, Scintigraphic studies on the corneal residence of a New Ophthalmic Delivery System (NODS): rate of clearance of a soluble marker in relation to duration of pharmacological action of pilocarpine, Br. J. Clin. Pharmacol. 33 (1992) 603-609.
11. P.P. Ellis, Commonly used eye preparations, in: D. Vaughan, T. Asbury, P. Riordan-Eva (Eds.), General Pharmacology, Prentice-Hall, London, 1992, p. 75.
12. M.C. Makoid, J.R. Robinson, Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye, J. Pharm. Sci. 68 (1979) 435-443.
13. V.H. Lee, J.R. Robinson, Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits, J. Pharm. Sci. 68 (1979) 673-684.
14. J.W. Sieg, J.R. Robinson, Mechanistic studies on transcorneal permeation of pilocarpine, J. Pharm. Sci. 65 (1979) 1818-1822.
15. V.H. Lee, J.P. Robinson, Disposition of pilocarpine in the pigmented rabbit eye, Int. J. Pharm. 11 (1982) 155-165.
16. T.F. Patton, M. Francoeur, Ocular bioavailability and systemic loss of topically applied ophthahmic drugs, Am. J. Ophthalmol. 85 (1978) 225-229.
17. H.Z. Klein, M. Lugo, M.B. Sheilds, E. Duzman, A dose-response study of Piloplex® for duration of action, Am. J. Ophthalmol. 99 (1985) 23-26.
18. J.M. Tanzer, P.A. Kramer, P. Schilman, A.K. Willard, A pharmacokinetic and pharmacidynamic study of intravenous pilocarpine in humans, J. Dental Res. 74 (1995) 1845-1849.
19. J.M. Conrad, W. Reay, R.-E. Polcyn, J.R. Robinson, Influence of tonicity and pH on lacrimation and ocular bioavailability, J. Parent. Drug Assoc. 32 (1978) 149-161.
20. P.M. Hughes, and A.-K. Mitra, Overview of ocular drug delivery and latrogenic ocular cytopathologies, in: A.K. Mitra (Ed.), Ophthalmic drug delivery systems, Marcel Dekker, New York, 1993, pp. 1-27.
21. I. Ahmed, B. Chaudhuri, Evaluation of buffer systems in ophthalmic product development, Int. J. Pharm. 44 (1988) 97-105.
22. P.H. Chung, T.F. Chin, J.L. Lach, Kinetics of the hydrolysis of pilocarpine in aqueous solution, J. Pharm. Sci, 59 (1970) 1300-1306.
23. J.D. Bartlett, M.D. Wesson, J. Swiatocha, T. Woolley, Efficacy of a paedriatric cycloplegic administered as a spray, J. Am. Optometric. Assoc. 9 (1993) 617-620.